Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06918977

Improving Glycemic Control With Telemedicine and Smart Insulin Pens

Led by University of Maryland, Baltimore · Updated on 2026-02-10

50

Participants Needed

2

Research Sites

121 weeks

Total Duration

On this page

Sponsors

U

University of Maryland, Baltimore

Lead Sponsor

M

Medtronic

Collaborating Sponsor

AI-Summary

What this Trial Is About

Almost 40% of veterans have diabetes, the proposed research may improve clinical care among veterans with diabetes. In this application we are going to examine whether utilizing Smart Insulin pens (SIPs) with CGMs and telemedicine is a better tool for managing diabetes compared to traditional insulin pens, CGMs and telemedicine, leading to improved blood sugar control and better clinical outcomes.

CONDITIONS

Official Title

Improving Glycemic Control With Telemedicine and Smart Insulin Pens

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years of age or older
  • Receiving multiple daily insulin injections (MDI) for at least 3 months before the study
Not Eligible

You will not qualify if you...

  • Not treated with MDI for at least 3 months (includes diet only, non-insulin medications only, basal insulin only, or short-acting insulin only)
  • Using insulin pumps at screening
  • Pregnant patients
  • Extensive skin disease or allergies preventing use of CGM sensor
  • End-stage renal disease requiring dialysis
  • Significant psychiatric illness or inability to understand study
  • Receiving hydroxyurea or chronic acetaminophen treatment
  • Started or changed dose of non-insulin diabetes medications within 60 days before study
  • No access to a compatible smartphone for digital health applications

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Baltimore VA Maryland Center

Baltimore, Maryland, United States, 21201

Actively Recruiting

2

VAMHCS, Diabetes Outpatient Clinic

Baltimore, Maryland, United States, 21201

Not Yet Recruiting

Loading map...

Research Team

W

William Scott, MS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Improving Glycemic Control With Telemedicine and Smart Insulin Pens | DecenTrialz